Novavax
NVAX
311 hedge funds and large institutions have $3.47B invested in Novavax in 2020 Q3 according to their latest regulatory filings, with 124 funds opening new positions, 90 increasing their positions, 80 reducing their positions, and 25 closing their positions.
500% more funds holding in top 10
Funds holding in top 10: 1 → 6 (+5)
396% more first-time investments, than exits
New positions opened: 124 | Existing positions closed: 25
46% more funds holding
Funds holding: 213 → 311 (+98)
22% more capital invested
Capital invested by funds: $2.84B → $3.47B (+$628M)
13% more repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 80
2.12% less ownership
Funds ownership: 54.81% → 52.7% (-2.1%)
20% less call options, than puts
Call options by funds: $463M | Put options by funds: $576M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$131M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$96.7M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$86.8M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$72.8M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$68.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$434M |
| 2 |
D.E. Shaw & Co
New York
|
-$121M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$93.6M |
| 4 |
Citigroup
New York
|
-$78.9M |
| 5 |
State Street
Boston,
Massachusetts
|
-$73.6M |
NVAX Hedge Fund Activity: Q3 2020 in Review
311 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q3 2020, worth a combined $3.47B — up 22% from $2.84B a quarter earlier.
Buyers outnumbered sellers: 124 funds opened new NVAX positions and 25 closed out — a net gain of 99 holders — while 90 added to existing stakes and 80 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $131M. The largest seller was RA Capital Management, cutting an estimated $434M.
- 311 institutional investors held Novavax (NVAX) as of Q3 2020, up from 213 in Q2 2020.
- Funds reported $3.47B of Novavax stock for Q3 2020, up 22% quarter-over-quarter.
- 124 funds opened new Novavax positions in Q3 2020 and 25 closed out, a net change of +99 holders.
- The largest Novavax buyer in Q3 2020 was Fidelity Investments, an estimated $131M added.
- The largest Novavax seller in Q3 2020 was RA Capital Management, an estimated $434M sold.
Based on aggregated 13F filings for Q3 2020.